We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+34.39%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$65.8B
AUM Growth
+$8.44B
Cap. Flow
-$768M
Cap. Flow %
-1.17%
Top 10 Hldgs %
21.16%
Holding
3,797
New
262
Increased
1,942
Reduced
1,268
Closed
186

Sector Composition

Rank Sector Weight
1 Technology 10.51%
2 Financials 8.9%
3 Healthcare 8.23%
4 Industrials 6.82%
5 Consumer Discretionary 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UVE icon
3101
Universal Insurance Holdings
UVE
$1.21B
$237K ﹤0.01%
7,656
-1,143
-13% -$41K
CBPX
3102
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$237K ﹤0.01%
9,560
-384
-4% -$10.1K
NVCR icon
3103
NovoCure
NVCR
$2.02B
$236K ﹤0.01%
4,902
-2,211
-31% -$106K
FBMS
3104
DELISTED
The First Bancshares, Inc.
FBMS
$236K ﹤0.01%
7,633
+995
+15% +$31.4K
MNK
3105
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$236K ﹤0.01%
+10,871
New +$232K
AIA icon
3106
iShares Asia 50 ETF
AIA
$4.91B
$234K ﹤0.01%
+3,830
New +$228K
ARKF icon
3107
ARK Blockchain & Fintech Innovation ETF
ARKF
$763M
$234K ﹤0.01%
+10,841
New +$227K
MKC.V icon
3108
McCormick & Company Voting
MKC.V
$14B
$234K ﹤0.01%
3,132
+12
+0.4% +$806
PCM
3109
PCM Fund
PCM
$70M
$234K ﹤0.01%
21,033
+859
+4% +$9.24K
PVL
3110
Permianville Royalty Trust
PVL
$57.8M
$234K ﹤0.01%
70,400
-5,412
-7% -$14.4K
PXLW icon
3111
Pixelworks
PXLW
$41M
$234K ﹤0.01%
4,975
ANIK icon
3112
Anika Therapeutics
ANIK
$277M
$233K ﹤0.01%
7,721
+1,600
+26% +$54.8K
EHTH icon
3113
eHealth
EHTH
$40.4M
$233K ﹤0.01%
3,738
-8,409
-69% -$463K
PG icon
3114
CALL
Procter & Gamble
PG
$340B
$233K ﹤0.01%
+6,200
New +$604K
WOR icon
3115
Worthington Enterprises
WOR
$2.79B
$233K ﹤0.01%
10,123
-71
-0.7% -$1.63K
KAMN
3116
DELISTED
Kaman Corp
KAMN
$233K ﹤0.01%
+3,984
New +$234K
BFO
3117
DELISTED
Blackrock Florida Municipal 2020 Term Trust
BFO
$233K ﹤0.01%
16,265
DVAX
3118
DELISTED
Dynavax Technologies
DVAX
$232K ﹤0.01%
31,803
+2,921
+10% +$28.6K
FMS icon
3119
Fresenius Medical Care
FMS
$13B
$232K ﹤0.01%
+5,736
New +$214K
SAM icon
3120
Boston Beer
SAM
$1.86B
$232K ﹤0.01%
+788
New +$216K
SGDM icon
3121
Sprott Gold Miners ETF
SGDM
$661M
$232K ﹤0.01%
12,264
+680
+6% +$12.7K
TCRT icon
3122
Alaunos Therapeutics
TCRT
$4.84M
$232K ﹤0.01%
402
+27
+7% +$11.3K
RAVN
3123
DELISTED
Raven Industries Inc
RAVN
$232K ﹤0.01%
6,044
-1,368
-18% -$51.9K
OIS icon
3124
Oil States International
OIS
$534M
$231K ﹤0.01%
+13,621
New +$230K
RWW
3125
DELISTED
Invesco S&P Financials Revenue ETF
RWW
$231K ﹤0.01%
3,685
+200
+6% +$12.6K

Similar funds

Raymond James & Associates's Q1 2019 Portfolio in Review

As of Q1 2019, Raymond James & Associates held 3,797 positions worth $65.8B, up 15% from $57.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q1 2019 filing shows 262 new, 1,942 increased, 1,268 reduced and 186 closed positions. Its largest new stake was iShares Currency Hedged MSCI Japan ETF: 509,963 shares worth $15.7M. The largest sale was TotalEnergies, an estimated $2.56B.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.8% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2019 buy was iShares Currency Hedged MSCI Japan ETF: 509,963 shares worth $15.7M.
  • Raymond James & Associates added most to iShares MSCI USA Min Vol Factor ETF in Q1 2019, an estimated $371M increase.
  • Raymond James & Associates's biggest Q1 2019 reduction was TotalEnergies, cutting an estimated $2.56B.
  • Raymond James & Associates fully exited iShares Core 80/20 Aggressive Allocation ETF in Q1 2019, selling an estimated $26.3M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $65.8B portfolio in Q1 2019.
  • Raymond James & Associates opened 262 new positions and closed 186 in Q1 2019.
  • Raymond James & Associates's portfolio value rose 15% quarter-over-quarter to $65.8B.

Based on Raymond James & Associates's 13F filing for Q1 2019, filed 6 May 2019.